AlTi Tiedemann Global’s campaign to boost its presence in the ultra-high-net-worth wealth space has just received a substantial shot in the arm.
The independent global wealth and alternatives manager announced that it’s received a strategic capital injection from Allianz X – an investment arm of insurance and asset management giant Allianz – and alternative asset manager Constellation Wealth Capital.
The strategic investment, which will add up to $450 million to AlTi’s war chest, includes an infusion of up to $300 million from Allianz X through one of its affiliates. Constellation, for its part, is kicking in $150 million.
AlTi plans to use that capital boost primarily to support its M&A activities, as well as organic growth efforts, which it says will expand the scale and reach of its global UHNW wealth management and strategic alternatives business.
“This investment accelerates AlTi’s trajectory to become the leading global independent UHNW wealth management platform, with strategic and targeted expertise in alternatives,” AlTi CEO Michael Tiedemann said in a statement.
Allianz X will invest $250 million through a combination of $110 million in class A common shares and $140 million in series A convertible preferred stock, with an option to invest an additional $50 million in series A convertible preferred shares.
Allianz X’s investment also gives it the right to nominate two directors to AlTi’s board of directors. It’s exercising that right with the planned appointment of Allianz X CEO Nazim Cetin, as well as another representative who’s yet to be named.
“Our investment in AlTi demonstrates our approach as well as our conviction in wealth management and alternatives, and we believe it will unlock opportunities for
Read more on investmentnews.com